Plasma levels of amyloid β proteins did not differ between subjects taking statins and those not taking statins [4]

Annals of Neurology

Volumn 49, Issue 4, 2001, Pages 546-547

  Tokuda, Takahiko ^a   Tamaoka, Akira ^a   Matsuno, Sayoko ^a   Sakurai, Shunpei ^a   Shimada, Hirohide ^b   Morita, Hiroshi ^a   Ikeda, Shu Ichi ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; PRAVASTATIN; SIMVASTATIN; STATIN;

ADULT; AGED; ALZHEIMER DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOREACTIVITY; LETTER; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED;

EID: 0035071528     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.112     Document Type: Letter

References (5)

1. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
2. Induction of Alzheimer-like β-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol
3. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
4. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants
5. Plasma levels of amyloid β proteins Aβ1-40 and Aβ1-42 (43) are elevated in Down's syndrome